Detalles de la búsqueda
1.
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
J Thromb Thrombolysis
; 51(2): 349-358, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588288
2.
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis.
Eur J Haematol
; 104(4): 328-335, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925840
3.
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis.
Thromb J
; 18: 6, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32292291
4.
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
Eur J Haematol
; 102(2): 143-149, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328143
5.
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
Diabetes Obes Metab
; 21(9): 2107-2114, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099460
6.
Methods for Measuring Multiple Medication Adherence: A Systematic Review-Report of the ISPOR Medication Adherence and Persistence Special Interest Group.
Value Health
; 22(2): 139-156, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30711058
7.
Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
J Thromb Thrombolysis
; 48(3): 366-372, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228038
8.
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
J Natl Compr Canc Netw
; 16(5): 491-497, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752323
9.
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.
J Thromb Thrombolysis
; 46(3): 339-345, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29881958
10.
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Stroke
; 48(8): 2142-2149, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28655814
11.
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.
BMC Pulm Med
; 17(1): 37, 2017 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193193
12.
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.
J Thromb Thrombolysis
; 42(4): 513-9, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324143
13.
Author's Reply.
Value Health
; 23(3): 407-408, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197738
14.
Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills.
Curr Med Res Opin
; 38(1): 19-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581258
15.
Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis.
TH Open
; 4(4): e344-e350, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145475
16.
Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
J Natl Med Assoc
; 112(4): 395-401, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493618
17.
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis.
Clin Appl Thromb Hemost
; 26: 1076029620954910, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085526
18.
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.
Blood Adv
; 4(17): 4045-4051, 2020 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853381
19.
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data.
Curr Med Res Opin
; 36(7): 1081-1088, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347755
20.
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
Eur Heart J Cardiovasc Pharmacother
; 6(3): 159-166, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31549153